Brže pretražujte lekove. Isprobajte Proveru interakcija između lekova.
Brže pretražujte lekove. Isprobajte Proveru interakcija između lekova.
HDRS — Hamiltonova skala depresije

HDRS — Hamiltonova skala depresije

Klinička procena težine depresije — 17 stavki, EPA/APA preporučena skala

No depression
0
Complete the scale based on a structured interview. Assessment should be based on the patient's condition in the past week.
Depressed mood (sadness, hopeless, helpless, worthless)
0 – Absent.
Feelings of guilt
0 – Absent.
Suicide
0 – Absent.
Insomnia: early in the night
0 – No difficulty falling asleep.
Insomnia: middle of the night
0 – No difficulty.
Insomnia: early hours of the morning
0 – No difficulty.
Work and activities
0 – No difficulty.
Retardation (slowness of thought and speech, impaired ability to concentrate, decreased motor activity)
0 – Normal speech and thought.
Agitation
0 – None.
Anxiety psychic
0 – No difficulty.
Anxiety somatic (physiological concomitants of anxiety)
0 – Absent.
Physiological concomitants:
• gastro-intestinal (dry mouth, wind, indigestion, diarrhea, cramps, belching);
• cardio-vascular (palpitations, headaches);
• respiratory (hyperventilation, sighing);
• urinary frequency;
• sweating.
Somatic symptoms gastro-intestinal
0 – None.
General somatic symptoms
0 – None.
Genital symptoms (symptoms such as loss of libido, menstrual disturbances)
0 – Absent.
Hypochondriasis
0 – Not present.
Insight
0 – Acknowledges being depressed and ill.
Are patient's weekly weight measurements available?
Loss of weight (according to the patient)
0 – No weight loss.

Dodatne informacije

Odštampajte ili sačuvajte kao PDF
Uputstva i reference

Upozorenje

Ova alatka služi isključivo u obrazovne svrhe i ne predstavlja profesionalni savet niti zamenu za profesionalni savet. Alatku ne treba koristiti za postavljanje medicinske dijagnoze i/ili pružanje medicinske terapije.
General description
The Hamilton Depression Rating Scale (abbreviated HDRS, HRSD or HAM-D), was published in 1967 and is one of the most commonly used instruments for assessing depression. It is a clinician-rated measure devised for use on patients already diagnosed with affective disorder of depressive type. HDRS has been used extensively in clinical research and in ordinary clinical practice for assessment of the severity of depression, changes in its severity over time, and efficacy of treatment. It should generally be used with the corresponding structured interview. Its value depends entirely on the skill of the interviewer in eliciting the necessary information.

The original version of HDRS is also one of the most commonly used versions; it contains 17 items pertaining to symptoms of depression experienced over the past week. However, the original study did not include thresholds for depression severity stratification. One commonly used set of thresholds was later developed by Mark Zimmerman et al. It can be used to classify patients into mild (8-16 points), moderate (17-23 points), and severe (≥ 24 points) depression.

The Hamilton Depression Rating Scale has been externally validated and is recommended by the European Psychiatric Association (EPA) and American Psychiatric Association (APA) guidelines as one of the suggested assessment instruments for ongoing clinical monitoring of depression and treatment effect assessment.

Result ranges

No depression
0–7
Mild depression
8–16
Moderate depression
17–23
Severe depression
≥ 24

Formula

Total score is calculated by summing all the points.

References

Hamilton, M. “A rating scale for depression.” Journal of neurology, neurosurgery, and psychiatry vol. 23,1 (1960): 56-62. doi:10.1136/jnnp.23.1.56
Zimmerman, Mark et al. “Severity classification on the Hamilton Depression Rating Scale.” Journal of affective disorders vol. 150,2 (2013): 384-8. doi:10.1016/j.jad.2013.04.028
Williams, J B. “A structured interview guide for the Hamilton Depression Rating Scale.” Archives of general psychiatry vol. 45,8 (1988): 742-7. doi:10.1001/archpsyc.1988.01800320058007

Verzija

1

Više o ovoj alatki

The Hamilton Depression Rating Scale (abbreviated HDRS, HRSD or HAM-D), was published in 1967 and is one of the most commonly used instruments for assessing depression. It is a clinician-rated measure devised for use on patients already diagnosed with affective disorder of depressive type. HDRS has been used extensively in clinical research and in ordinary clinical practice for assessment of the severity of depression, changes in its severity over time, and efficacy of treatment. It should generally be used with the corresponding structured interview. Its value depends entirely on the skill of the interviewer in eliciting the necessary information.

The original version of HDRS is also one of the most commonly used versions; it contains 17 items pertaining to symptoms of depression experienced over the past week. However, the original study did not include thresholds for depression severity stratification. One commonly used set of thresholds was later developed by Mark Zimmerman et al. It can be used to classify patients into mild (8-16 points), moderate (17-23 points), and severe (≥ 24 points) depression.

The Hamilton Depression Rating Scale has been externally validated and is recommended by the European Psychiatric Association (EPA) and American Psychiatric Association (APA) guidelines as one of the suggested assessment instruments for ongoing clinical monitoring of depression and treatment effect assessment.
Drugs app phone

Koristite aplikaciju Mediately

Dobijte informacije o lekovima brže.

Skenirajte kamerom telefona.
4.9

Više 36k ocene

Koristite aplikaciju Mediately

Dobijte informacije o lekovima brže.

4.9

Više 36k ocene

Instaliraj

Idite dalje od informacija o lekovima uz PRO

Rešite interakcije, pregledajte ograničenja upotrebe i pronađite sve ostale odgovore uz pomoć svog AI asistenta Elly.

Preveri, kaj ponuja PRO
Koristimo kolačiće Kolačići nam pomažu da pružimo najbolje iskustvo na našoj veb stranici. Korišćenjem naše veb stranice saglasni ste sa upotrebom kolačića. Više o tome kako koristimo kolačiće saznajte u našoj Politici kolačića.